Genitourinary (Prostate, Bladder) System Archives - Page 7 of 9 - Together4Cancer Compass

Patients

HCPs

Home

Categories

P21-positive senescent stromal cells promote prostate cancer immune suppression and progression that can be reversed by senolytic therapy.

Post category:Genitourinary (Prostate, Bladder) System
Reading time:1 min read

This study investigates the role of cellular senescence in prostate cancer progression, focusing on p16+ and p21+ senesc...

Continue Reading

Multi-institutional validation of AI models for classifying urothelial neoplasms in digital pathology.

Post category:Genitourinary (Prostate, Bladder) System
Reading time:1 min read

This study presents a deep learning approach using convolutional neural networks and transformer-based models to classif...

Continue Reading

Autocatalytic Signal Amplification via Orthogonal Recognition of Dual Proteins on the Surface of Serum Extracellular Vesicles for Precise Diagnosis of Prostate Cancer.

Post category:Genitourinary (Prostate, Bladder) System
Reading time:1 min read

This study presents a novel dual-protein orthogonal triggered autocatalytic signal amplification (DOTASA) strategy to im...

Continue Reading

[Options in nuclear medicine for advanced prostate cancer in practice].

Post category:Genitourinary (Prostate, Bladder) System
Reading time:1 min read

This publication reviews recent advances in prostate-specific membrane antigen (PSMA) positron emission tomography/compu...

Continue Reading

Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial.

Post category:Genitourinary (Prostate, Bladder) System
Reading time:1 min read

The AMPLITUDE trial investigated the efficacy of adding niraparib, a PARP inhibitor, to abiraterone acetate and predniso...

Continue Reading

Inlexzo (gemcitabine intravesical system): promising data but key questions remain.

Post category:Genitourinary (Prostate, Bladder) System
Reading time:1 min read

The FDA approval of Inlexzo (gemcitabine intravesical system) marks a significant advance in bladder-sparing treatment f...

Continue Reading